Navigation Links
New Study Shows Many Unplanned Quit Smoking Attempts are Successful
Date:7/1/2009

PARSIPPANY, N.J., July 1 - Data published in the journal, Nicotine and Tobacco Research, shows that many U.S. quit attempts are unplanned and can be a successful route to cessation. In the study, almost 40 percent of subjects reported that their most recent quit attempt started without any advance planning, suggesting that for some smokers, setting an advance quit date may not be as necessary as once thought.

While a period of planning prior to quitting has long been thought to allow smokers time to prepare themselves for their quit attempt, the study explores the various reasons as well as demographic and psychographic data which may contribute to a smoker deciding to quit spontaneously.

"The study examines the possibility that while quit attempts may seem like spontaneous efforts on the surface, they may actually be the result of prolonged subconscious dissatisfaction with or concern about one's smoking. The results do not discredit planning out a quit attempt, however, a smoker needs to determine what may be the best approach to ensure long-term cessation," said Dr. Saul Shiffman, professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh and study co-author. "All smokers should consider ways to manage tough situations such as cravings and withdrawal symptoms to ensure long-term success."

Smokers who make an unplanned quit attempt can improve their chances significantly by getting help and support from proven stop smoking tools such as therapeutic nicotine products like Nicorette(R), NicoDerm(R) CQ(R) and Commit(R). Consistent with their FDA-approved labeling, therapeutic nicotine products help reduce nicotine withdrawal symptoms, including nicotine craving, associated with quitting smoking. Smokers who quit spontaneously can also access therapeutic nicotine medicines which are available over the counter without a doctor's prescription at more than 35,000 retail outlets.

About the Study

A study of 1,700 adults (900 adults age 18 and over who currently smoke cigarettes every day and 800 adults, age 18 and over, who previously smoked every day but quit between one month and ten years ago) were recruited from an online U.S. market research database (Survey Sampling International, Shelton, CT) and completed an online survey. Random samples of both panels were sent an e-mail that contained a link to an online survey.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples -- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.

    Contacts:  Mark Polisky, GolinHarris
               312-729-4417
               mpolisky@golinharris.com

               Debbie Bolding,
               GlaxoSmithKline
               Consumer Healthcare
               412-200-3872
               deborah.g.bolding@gsk.com


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Study examines dietary influences of liver disease
2. Study examines liver transplantation after drug induced acute liver failure
3. Study Supports Wider Use of Statins
4. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
5. The European Association for the Study of the Liver renews publishing partnership with Elsevier
6. Study to see if video games can boost thinking skills in elderly
7. GIE: Gastrointestinal Endoscopy June issue study highlights
8. Study shows 1 in 25 deaths worldwide attributable to alcohol
9. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
10. U-M study finds voice box can be preserved, even with the largest cancers
11. Clinical Study Data Indicates that Celliant Reduces Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... 21, 2017 , ... The American Hospital Association (AHA) has elected Claire Zangerle, ... to its Board of Trustees for a three-year term beginning January 1, 2018. ... and individuals that are committed to the improvement of health in their communities. Founded ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA ... Management System has assisted multiple clients in successfully passing audits such as ... Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
(Date:8/19/2017)... ... August 18, 2017 , ... Paragon and ... to help the cannabis industry move towards greater legitimacy. By incorporating IOTA’s unique ... technology with lower fees. Paragon will build a fully verifiable database to track ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... Yesterday, the ... KKK by saying there are two sides. There are not two sides to hatred, ... to rationalize violence and prejudice, and the NPEIV stands against all forms of such ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology: